Navigation Links
Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
Date:8/11/2008

NEW YORK, Aug. 11 /PRNewswire-FirstCall/ -- Duff & Phelps Corporation (NYSE: DUF), a leading independent financial advisory and investment banking firm, today announced that it has acquired the Lumin Expert Group (Lumin). Lumin is a financial consulting firm that specializes in intellectual property dispute support and expert testimony. Financial terms of the transaction were not disclosed.

Lumin performs independent analyses of financial, economic and business issues across a number of industries. Lumin's services include the assessment of economic damages, expert testimony and business consulting services which include reasonable royalty determinations and strategic consulting in intellectual property licensing matters.

Gerry Creagh, President of Duff & Phelps, said, "I am very excited that this team of well regarded experts is joining Duff & Phelps. Adding a high quality intellectual property and commercial litigation practice is consistent with our corporate mission of protecting, recovering and maximizing value for our clients."

Lumin has nine employees and is headquartered in Houston, Texas. Lumin will operate under the Duff & Phelps brand and merge with the Duff & Phelps Dispute and Legal Management Consulting business.

Greg Higgins, head of the Dispute and Legal Management Consulting practice, said, "As intellectual property continues to proliferate, so do disputes in connection with ownership and infringement. As a market leader of intellectual property valuation services, the acquisition of Lumin is a natural fit as we build out a global intellectual property practice."

Thomas Britven, President of Lumin Expert Group, said, "We are very excited to join a firm with the reputation of Duff & Phelps. Our clients will benefit from the firm's expanded service offering, extensive resources with deep technical and industry expertise and global network."

About Duff & Phelps

Duff & Phelps Corporation (NYSE: DUF) is a leading provider of independent financial advisory and investment banking services, supporting client needs principally in the areas of valuation, transactions, financial restructurings and disputes. With more than 1,100 employees serving clients worldwide through offices in North America, Europe and Asia, Duff & Phelps is committed to fulfilling its mission to protect, recover and maximize value for its clients. Investment banking services are provided by Duff & Phelps Securities, LLC. Duff & Phelps Securities, Ltd. is authorized and regulated by The Financial Services Authority. For more information visit http://www.duffandphelps.com.


'/>"/>
SOURCE Duff & Phelps Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Proteon Therapeutics Appoints Experienced Biopharmaceutical Executive, Gregory D. Phelps to its Board of Directors
2. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
3. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
4. MacroGenics Acquires Raven Biotechnologies
5. Warburg Pincus Acquires 5.4% of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank
6. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
7. Neogen Acquires Product Line From DuPont Animal Health Solutions
8. Decision Resources, Inc. Acquires Manhattan Research
9. Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.
10. Miltenyi Biotec GmbH Acquires Medic Tools AG
11. Pacific Biosciences Acquires Single Molecule Sequencing Technology from LI-COR Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced ... U.K. Biobank and GSK to generate genetic sequence data from ... initiative will enable researchers to gain valuable insights to support ... range of serious and life threatening diseases. ... Genetic evidence has ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical , ... therapeutics designed to target cancer stemness pathways, today announced ... Andrews as Chief Executive Officer, effective April 24, ... Chiang J. Li , M.D., FACP, who has led ... ago. Under his leadership, Boston Biomedical has grown from ...
(Date:3/22/2017)... Maryland (PRWEB) , ... March 21, 2017 , ... ... Life Science Chief Executive Officer Forum on March 23-24 in San Diego. The ... medical device and diagnostic industries. , Benchworks Vice President Christian Meyer will also ...
Breaking Biology Technology:
(Date:3/22/2017)...   Neurotechnology , a provider of high-precision ... the release of the SentiVeillance 6.0 ... recognition using up to 10 surveillance, security and ... new version uses deep neural-network-based facial detection and ... a Graphing Processing Unit (GPU) for enhanced speed. ...
(Date:3/20/2017)... PMD Healthcare announces the release of its ... System (WMS), a remote, real-time lung health monitoring and ... is a Medical Device, Digital Health, and Chronic Care ... innovative solutions that empower people to improve their healthcare ... developed the first ever personal spirometer, Spiro PD, which ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , March ... Made Simple," and 23andMe , the leading personal ... food choices.  Zipongo can now provide customers with personalized ... health goals and biometrics, but also genetic markers impacting ... Zipongo,s personalized food decision support platform uses ...
Breaking Biology News(10 mins):